HRP20110683T1 - Postupak za sintezu ivabradina i njegovih farmaceutski prihvatljivih kiselih adicijskih soli - Google Patents
Postupak za sintezu ivabradina i njegovih farmaceutski prihvatljivih kiselih adicijskih soli Download PDFInfo
- Publication number
- HRP20110683T1 HRP20110683T1 HR20110683T HRP20110683T HRP20110683T1 HR P20110683 T1 HRP20110683 T1 HR P20110683T1 HR 20110683 T HR20110683 T HR 20110683T HR P20110683 T HRP20110683 T HR P20110683T HR P20110683 T1 HRP20110683 T1 HR P20110683T1
- Authority
- HR
- Croatia
- Prior art keywords
- acid
- formula
- compound
- trifluoromethanesulfonate
- iii
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title claims abstract 6
- 238000000034 method Methods 0.000 title claims abstract 6
- 238000003786 synthesis reaction Methods 0.000 title claims abstract 6
- 239000002253 acid Substances 0.000 title claims 3
- ACRHBAYQBXXRTO-OAQYLSRUSA-N ivabradine Chemical compound C1CC2=CC(OC)=C(OC)C=C2CC(=O)N1CCCN(C)C[C@H]1CC2=C1C=C(OC)C(OC)=C2 ACRHBAYQBXXRTO-OAQYLSRUSA-N 0.000 title claims 3
- 229960003825 ivabradine Drugs 0.000 title claims 3
- 150000003839 salts Chemical class 0.000 title claims 3
- 150000001875 compounds Chemical class 0.000 claims abstract 23
- 239000003795 chemical substances by application Substances 0.000 claims abstract 5
- 150000004678 hydrides Chemical class 0.000 claims abstract 5
- 239000002904 solvent Substances 0.000 claims abstract 4
- -1 transition metal salt Chemical class 0.000 claims abstract 4
- 229910052747 lanthanoid Inorganic materials 0.000 claims abstract 3
- 229910052723 transition metal Inorganic materials 0.000 claims abstract 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 3
- 238000006243 chemical reaction Methods 0.000 claims 3
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 claims 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims 2
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 claims 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 claims 2
- 239000011668 ascorbic acid Substances 0.000 claims 2
- 235000010323 ascorbic acid Nutrition 0.000 claims 2
- 229960005070 ascorbic acid Drugs 0.000 claims 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims 2
- 229940092714 benzenesulfonic acid Drugs 0.000 claims 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims 2
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 claims 2
- 235000015165 citric acid Nutrition 0.000 claims 2
- 239000001530 fumaric acid Substances 0.000 claims 2
- 150000004677 hydrates Chemical class 0.000 claims 2
- 239000004310 lactic acid Substances 0.000 claims 2
- 235000014655 lactic acid Nutrition 0.000 claims 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 2
- 239000011976 maleic acid Substances 0.000 claims 2
- 229940098779 methanesulfonic acid Drugs 0.000 claims 2
- 235000006408 oxalic acid Nutrition 0.000 claims 2
- 229940107700 pyruvic acid Drugs 0.000 claims 2
- 238000001308 synthesis method Methods 0.000 claims 2
- 239000011975 tartaric acid Substances 0.000 claims 2
- 235000002906 tartaric acid Nutrition 0.000 claims 2
- 150000003624 transition metals Chemical class 0.000 claims 2
- SGADWDZEFVJPHP-UHFFFAOYSA-N 4-chloro-6-methylfuro[2,3-d]pyrimidine Chemical compound N1=CN=C2OC(C)=CC2=C1Cl SGADWDZEFVJPHP-UHFFFAOYSA-N 0.000 claims 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 claims 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims 1
- ZKQDAXHUGUXLHZ-UHFFFAOYSA-N [Cu+].[Br+] Chemical compound [Cu+].[Br+] ZKQDAXHUGUXLHZ-UHFFFAOYSA-N 0.000 claims 1
- 230000001476 alcoholic effect Effects 0.000 claims 1
- YJROYUJAFGZMJA-UHFFFAOYSA-N boron;morpholine Chemical compound [B].C1COCCN1 YJROYUJAFGZMJA-UHFFFAOYSA-N 0.000 claims 1
- RJTANRZEWTUVMA-UHFFFAOYSA-N boron;n-methylmethanamine Chemical class [B].CNC RJTANRZEWTUVMA-UHFFFAOYSA-N 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 claims 1
- XSVCYDUEICANRJ-UHFFFAOYSA-K dysprosium(3+);trifluoromethanesulfonate Chemical compound [Dy+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F XSVCYDUEICANRJ-UHFFFAOYSA-K 0.000 claims 1
- GLQOFBCJADYRKR-UHFFFAOYSA-K erbium(3+);trifluoromethanesulfonate Chemical compound [Er+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F GLQOFBCJADYRKR-UHFFFAOYSA-K 0.000 claims 1
- TWNOVENTEPVGEJ-UHFFFAOYSA-K europium(3+);trifluoromethanesulfonate Chemical compound [Eu+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F TWNOVENTEPVGEJ-UHFFFAOYSA-K 0.000 claims 1
- DYOBTPTUHDTANY-UHFFFAOYSA-K gadolinium(3+);trifluoromethanesulfonate Chemical compound [Gd+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F DYOBTPTUHDTANY-UHFFFAOYSA-K 0.000 claims 1
- DBPDCYACEYLEMY-UHFFFAOYSA-K holmium(3+);trifluoromethanesulfonate Chemical compound [Ho+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F DBPDCYACEYLEMY-UHFFFAOYSA-K 0.000 claims 1
- NRMNRSCGHRWJAK-UHFFFAOYSA-K lutetium(3+);trifluoromethanesulfonate Chemical compound [Lu+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F NRMNRSCGHRWJAK-UHFFFAOYSA-K 0.000 claims 1
- WYRSPTDNOIZOGA-UHFFFAOYSA-K neodymium(3+);trifluoromethanesulfonate Chemical compound [Nd+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F WYRSPTDNOIZOGA-UHFFFAOYSA-K 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- ROUBZIWQWFQCHU-UHFFFAOYSA-K praseodymium(3+);trifluoromethanesulfonate Chemical compound [Pr+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F ROUBZIWQWFQCHU-UHFFFAOYSA-K 0.000 claims 1
- DDCWGUIPLGMBPO-UHFFFAOYSA-K samarium(3+);trifluoromethanesulfonate Chemical compound [Sm+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F DDCWGUIPLGMBPO-UHFFFAOYSA-K 0.000 claims 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 claims 1
- JLYAVYSVLLIWEK-UHFFFAOYSA-K terbium(3+);trifluoromethanesulfonate Chemical compound [Tb+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F JLYAVYSVLLIWEK-UHFFFAOYSA-K 0.000 claims 1
- JPJIEXKLJOWQQK-UHFFFAOYSA-K trifluoromethanesulfonate;yttrium(3+) Chemical compound [Y+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F JPJIEXKLJOWQQK-UHFFFAOYSA-K 0.000 claims 1
- 150000002602 lanthanoids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0901556A FR2943668B1 (fr) | 2009-03-31 | 2009-03-31 | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable. |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20110683T1 true HRP20110683T1 (hr) | 2011-10-31 |
Family
ID=40983371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20110683T HRP20110683T1 (hr) | 2009-03-31 | 2011-09-22 | Postupak za sintezu ivabradina i njegovih farmaceutski prihvatljivih kiselih adicijskih soli |
Country Status (35)
Country | Link |
---|---|
US (1) | US8119794B2 (ru) |
EP (1) | EP2241553B1 (ru) |
JP (1) | JP5107381B2 (ru) |
KR (1) | KR101166632B1 (ru) |
CN (1) | CN101851204B (ru) |
AR (1) | AR075978A1 (ru) |
AT (1) | ATE517093T1 (ru) |
AU (1) | AU2010201035B2 (ru) |
BR (1) | BRPI1000865A2 (ru) |
CA (1) | CA2697563C (ru) |
CL (1) | CL2010000253A1 (ru) |
CY (1) | CY1111914T1 (ru) |
DK (1) | DK2241553T3 (ru) |
EA (1) | EA016353B1 (ru) |
ES (1) | ES2370150T3 (ru) |
FR (1) | FR2943668B1 (ru) |
GE (1) | GEP20125446B (ru) |
HK (1) | HK1148749A1 (ru) |
HR (1) | HRP20110683T1 (ru) |
JO (1) | JO2781B1 (ru) |
MA (1) | MA31746B1 (ru) |
ME (1) | ME00986B (ru) |
MX (1) | MX2010003213A (ru) |
MY (1) | MY150014A (ru) |
NZ (1) | NZ584310A (ru) |
PE (1) | PE20110098A1 (ru) |
PL (1) | PL2241553T3 (ru) |
RS (1) | RS51920B (ru) |
SA (1) | SA110310239B1 (ru) |
SI (1) | SI2241553T1 (ru) |
TW (1) | TWI376371B (ru) |
UA (1) | UA105894C2 (ru) |
UY (1) | UY32499A (ru) |
WO (1) | WO2010112705A1 (ru) |
ZA (1) | ZA201002120B (ru) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101478855B1 (ko) * | 2007-05-30 | 2015-01-02 | 인드-스위프트 래버러토리즈 리미티드 | 이바브라딘 히드로클로라이드 및 그의 다형태의 제조방법 |
FR2971507B1 (fr) * | 2011-02-14 | 2013-01-18 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2984320B1 (fr) * | 2011-12-20 | 2013-11-29 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2988720B1 (fr) * | 2012-03-27 | 2014-03-14 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
CN103848789B (zh) * | 2012-11-29 | 2016-05-18 | 江苏恒瑞医药股份有限公司 | 一种伊伐布雷定的制备方法 |
EP3101010A1 (en) | 2015-06-03 | 2016-12-07 | Urquima S.A. | New method for the preparation of highly pure ivabradine base and salts thereof |
CN113372273B (zh) * | 2020-03-10 | 2023-05-09 | 鲁南制药集团股份有限公司 | 一种伊伐布雷定中间体化合物iv |
CN113372274B (zh) * | 2020-03-10 | 2023-03-24 | 鲁南制药集团股份有限公司 | 一种伊伐布雷定的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3119874A1 (de) * | 1981-05-19 | 1982-12-09 | Dr. Karl Thomae Gmbh, 7950 Biberach | "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel" |
FR2681862B1 (fr) * | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
FR2868777B1 (fr) * | 2004-04-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2870537A1 (fr) * | 2004-05-19 | 2005-11-25 | Servier Lab | Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
KR101478855B1 (ko) | 2007-05-30 | 2015-01-02 | 인드-스위프트 래버러토리즈 리미티드 | 이바브라딘 히드로클로라이드 및 그의 다형태의 제조방법 |
-
2009
- 2009-03-31 ME MEP-2010-54A patent/ME00986B/me unknown
- 2009-03-31 FR FR0901556A patent/FR2943668B1/fr not_active Expired - Fee Related
-
2010
- 2010-03-16 PE PE2010000155A patent/PE20110098A1/es not_active Application Discontinuation
- 2010-03-17 AU AU2010201035A patent/AU2010201035B2/en not_active Ceased
- 2010-03-17 UY UY0001032499A patent/UY32499A/es not_active Application Discontinuation
- 2010-03-17 MY MYPI2010001175A patent/MY150014A/en unknown
- 2010-03-18 MA MA32705A patent/MA31746B1/fr unknown
- 2010-03-22 CL CL2010000253A patent/CL2010000253A1/es unknown
- 2010-03-24 CA CA2697563A patent/CA2697563C/fr not_active Expired - Fee Related
- 2010-03-24 MX MX2010003213A patent/MX2010003213A/es active IP Right Grant
- 2010-03-25 ZA ZA2010/02120A patent/ZA201002120B/en unknown
- 2010-03-29 GE GEAP201011742A patent/GEP20125446B/en unknown
- 2010-03-29 AR ARP100101003A patent/AR075978A1/es not_active Application Discontinuation
- 2010-03-29 UA UAA201003585A patent/UA105894C2/ru unknown
- 2010-03-29 SA SA110310239A patent/SA110310239B1/ar unknown
- 2010-03-29 TW TW099109448A patent/TWI376371B/zh not_active IP Right Cessation
- 2010-03-29 US US12/798,048 patent/US8119794B2/en not_active Expired - Fee Related
- 2010-03-29 NZ NZ584310A patent/NZ584310A/en not_active IP Right Cessation
- 2010-03-30 EA EA201000398A patent/EA016353B1/ru not_active IP Right Cessation
- 2010-03-30 BR BRPI1000865-9A patent/BRPI1000865A2/pt not_active Application Discontinuation
- 2010-03-30 PL PL10290165T patent/PL2241553T3/pl unknown
- 2010-03-30 DK DK10290165.9T patent/DK2241553T3/da active
- 2010-03-30 AT AT10290165T patent/ATE517093T1/de active
- 2010-03-30 WO PCT/FR2010/000269 patent/WO2010112705A1/fr active Application Filing
- 2010-03-30 JP JP2010076767A patent/JP5107381B2/ja active Active
- 2010-03-30 EP EP10290165A patent/EP2241553B1/fr active Active
- 2010-03-30 SI SI201030007T patent/SI2241553T1/sl unknown
- 2010-03-30 ES ES10290165T patent/ES2370150T3/es active Active
- 2010-03-30 RS RS20110377A patent/RS51920B/en unknown
- 2010-03-31 CN CN2010101546876A patent/CN101851204B/zh not_active Expired - Fee Related
- 2010-03-31 KR KR1020100029269A patent/KR101166632B1/ko active IP Right Grant
- 2010-03-31 JO JO2010103A patent/JO2781B1/en active
-
2011
- 2011-03-28 HK HK11103104.4A patent/HK1148749A1/xx not_active IP Right Cessation
- 2011-09-22 HR HR20110683T patent/HRP20110683T1/hr unknown
- 2011-10-06 CY CY20111100957T patent/CY1111914T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20110683T1 (hr) | Postupak za sintezu ivabradina i njegovih farmaceutski prihvatljivih kiselih adicijskih soli | |
HRP20110915T1 (hr) | Postupak za sintezu ivabradina i njegove farmaceutski prihvatljive kisele adicijske soli | |
US6541639B2 (en) | Efficient ligand-mediated Ullmann coupling of anilines and azoles | |
JP4986122B2 (ja) | 電解アルミニウムめっき液およびアルミニウムめっき膜 | |
CN104520275B (zh) | 用于制备整合酶抑制剂的方法和中间产物 | |
EP2243805B1 (en) | Anthrapyridone compound or salt thereof, magenta ink composition containing the anthrapyridone compound, and colored body | |
CN106478503A (zh) | Roxadustat中间体的制备方法 | |
CN109988077A (zh) | 一种阿帕鲁胺的合成方法及中间体 | |
HRP20120955T1 (hr) | Novi postupak za sintetiziranje ivabradina i njegovih adicijskih soli | |
CN102812009B (zh) | 用于合成5-氨基,1-苯基,3-氰基,4-三氟甲基亚磺酰基吡唑的方法 | |
KR20160027536A (ko) | 실로도신 합성에 유용한 중간체의 제조방법 | |
KR101040729B1 (ko) | 페릴렌 단위를 포함하는 수용성 적색염료 화합물, 그제조방법, 이를 포함한 잉크 조성물 및 컬러필터 | |
JP3592991B2 (ja) | 補償されたスルホン化ポリアニリン及びその調製方法 | |
CN111019651A (zh) | 一种荧光卤化铅材料的水相合成方法 | |
CN103467355A (zh) | 一种吲达帕胺的制备方法 | |
CN115094449B (zh) | 一种利用氟利昂型甲烷作为碳一合成子合成标记卤代吲哚酮的方法及其应用 | |
CN103709089A (zh) | 一种制备3-(4’-氯丁基)-5-氰基吲哚的方法 | |
US8481727B2 (en) | Crystals of hydrochloride of pyridazin-3(2H)-one compound and process for production of same | |
US11512044B2 (en) | Method for preparing salicylamine acetate | |
EP3816238B9 (en) | Polyparaperylene derivatives and methods for making same | |
RU2420515C2 (ru) | Способ получения 3,4,5-трифторанилина | |
JP2007161757A (ja) | 芳香族ジアミン/芳香族ジカルボン酸塩およびその製造方法 | |
JP2010518178A5 (ru) | ||
ITMI20121576A1 (it) | Procedimento per la preparazione di vilazodone |